A

Alnylam Pharmaceuticals

Develops RNAi-based therapies for genetic diseases

Director, Clinical Science

Clinical Research OperationsUpdated on Nov 6
Full-timeUnited States$205.7k - $278.3k

About the Job

Requirements

  • A college degree in life sciences or a nursing degree is required; an advanced degree such as a PhD, PharmD, or MS is preferred.
  • At least 10 years of experience in the pharmaceutical or biotechnology industry is required.
  • Experience in cardiovascular studies and large outcome trials is preferred.
  • A proven track record of successfully executing multiple proof-of-concept and pivotal trials is required.
  • Experience with new drug application submissions and Health Authority interactions is a plus.
  • Scientific and analytical ability, strategic and tactical thinking, interest in applied clinical research, and the ability to work effectively in multifunctional and multinational teams and multitask and prioritize are needed.
  • Proven experience developing effective relationships with key investigators is required.
  • Experience leading a team in a matrix setting is required.

Responsibilities

  • Maintain current scientific and clinical knowledge in assigned therapeutic and disease areas as the clinical science expert for assigned studies.
  • Independently lead the clinical execution of one or more studies and potentially be accountable for program-level clinical deliverables.
  • Provide input to protocol design documents and lead development of protocols, protocol amendments, Protocol Administrative Change Letters, and Dear Investigator Letters.
  • Represent the clinical science team in internal protocol review committees and partner with or support the Clinical Research Lead on study and disease-area strategy; participate in protocol-related key opinion leader and Health Authority interactions as appropriate.
  • Ensure development of Study Informed Consent Documents and responses to requests from external stakeholders, including Health Authorities and Independent Ethics Committees.
  • Provide clinical guidance on the Statistical Analysis Plan and its Tables, Listings, and Figures.
  • Provide clinical guidance on clinical data collection strategy, instruments, and the data review plan, aligning them with the protocol and Statistical Analysis Plan, optimized data collection principles, and clinical data review best practices.
  • Set the clinical data review strategy; lead review of emerging clinical data and trends; review and query data; present data to internal and external stakeholders; support site-facing colleagues in resolving data issues; and ensure clinical queries are addressed in support of database lock.
  • Collaborate with Medical Safety and Pharmacovigilance on the Safety Review Plan and Safety Narrative Plan; review safety data, update clinical documents in response to emerging safety profiles, lead clinical safety discussions during Safety Review Team meetings with medically qualified individuals, and review safety narratives.
  • Provide clinical guidance on the Risk Management Plan; ensure clinical activities follow the approved plan and partner with stakeholders to develop and implement risk mitigations.
  • Collaborate with the medical monitor to establish and manage External Data Monitoring Committees and Adjudication Committees, including chartering, data provision and presentation, and documentation and dissemination of committee recommendations as appropriate.
  • Develop site selection criteria, provide clinical input to site selection, and ensure protocol training is delivered to site-facing colleagues.
  • Participate in investigator meeting planning and develop and deliver protocol training, including ongoing training responding to protocol amendments, emerging data issues, and quality events.
  • Serve as the primary clinical point of contact for investigators and the study team on protocol-related clinical questions; manage clinical response development, delivery, documentation, and curation, such as in frequently asked questions.
  • Ensure protocol deviation subcategories are established, deviations identified during clinical data review are reported, reported deviations are managed and reconciled, and deviation trends are reviewed.
  • Ensure Trial Master File compliance for clinical documents.
  • Provide clinical input to and review the Clinical Study Report.
  • Ensure disclosure of safety and efficacy data and trial conclusions; contribute to primary publications as appropriate.
  • Provide clinical support for audits and inspections, including responding to and addressing findings.
  • Contribute to clinical sections of regulatory filings as appropriate, including briefing documents, Pediatric Investigational Plans, Investigator Brochures, Investigational New Drug or New Drug Application annual reports, Periodic Safety Update Reports, and responses to Health Authority requests.
  • Contribute to continuous improvement, process enhancement, and innovative approaches to maximize clinical trial execution effectiveness.
  • May have managerial responsibility for other clinical colleagues or contingent workers and may supervise, mentor, or develop others.

Desired Qualifications

  • Experience in cardiovascular and large outcome trials.
  • Experience with new drug application submissions and Health Authority interactions.
  • An advanced degree such as a PhD, PharmD, or MS.

About the Company

Alnylam Pharmaceuticals

Develops RNAi-based therapies for genetic diseases

Alnylam Pharmaceuticals develops RNA interference (RNAi) therapeutics to silence disease-causing genes, aiming to treat rare genetic disorders. Its products work by using RNA molecules that block gene expression, reducing the impact of specific genetic diseases. The company differentiates itself by concentrating on RNAi-based drugs for rare diseases and by building a pipeline through large clinical programs and strategic partnerships, such as commercialization deals in the Gulf States and collaborations with investors. Revenue comes from approved drug sales, licensing agreements, strategic collaborations, and related services like genetic testing and counseling. The company’s goal is to advance and commercialize RNAi therapies to improve outcomes for patients with genetic disorders, expanding its portfolio through partnerships and investments.

Company size
1,001-5,000
Company stage
IPO
Headquarters
Cambridge, MA
Founded
2002

Recently Posted Jobs

Explore more opportunities at Alnylam Pharmaceuticals

See more jobs